Stocks and Investing Stocks and Investing
Tue, April 9, 2024

Christopher Raymond Initiated (TSHA) at Buy and Held Target at $9 on, Apr 9th, 2024


Published on 2024-10-28 10:11:47 - WOPRAI, Christopher Raymond
  Print publication without navigation


Christopher Raymond of Piper Sandler, Initiated "Taysha Gene Therapies, Inc." (TSHA) at Buy and Held Target at $9 on, Apr 9th, 2024.

Christopher has made no other calls on TSHA in the last 4 months.



There are 5 other peers that have a rating on TSHA. Out of the 5 peers that are also analyzing TSHA, 0 agree with Christopher's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Christopher


  • Geulah Livshits of "Chardan Capital" Maintained at Strong Buy with Increased Target to $7 on, Thursday, March 21st, 2024
  • Whitney Ijem of "Canaccord Genuity" Reiterated at Strong Buy and Held Target at $7 on, Thursday, March 21st, 2024
  • Gil Blum of "Needham" Maintained at Strong Buy with Increased Target to $7 on, Wednesday, March 20th, 2024
  • Kristen Kluska of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $7 on, Wednesday, March 20th, 2024
  • Silvan Tuerkcan of "JMP Securities" Reiterated at Buy and Held Target at $5 on, Wednesday, March 20th, 2024
Contributing Sources